The fecal lactoferrin levels in IBD patients were significantly higher compared to both IBS patients and the healthy control group, highlighting its potential as a biomarker for distinguishing IBD from non-inflammatory conditions. The gene discussed is LTF; the disease is irritable bowel syndrome.